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Abstract
Changes in endothelial glycocalyx are one of the earliest changes in development of cardiovascular disease. The endothelial
glycocalyx is both an important biological modifier of interactions between flowing blood and the vessel wall, and a
determinant of organ perfusion. We hypothesize that deeper penetration of erythrocytes into the glycocalyx is associated
with reduced microvascular perfusion. The population-based prospective cohort study (the Netherlands Epidemiology of
Obesity [NEO] study) includes 6,673 middle-aged individuals (oversampling of overweight and obese individuals). Within
this cohort, we have imaged the sublingual microvasculature of 915 participants using sidestream darkfield (SDF) imaging
together with a recently developed automated acquisition and analysis approach. Presence of RBC (as a marker of
microvascular perfusion) and perfused boundary region (PBR), a marker for endothelial glycocalyx barrier properties for RBC
accessibility, were assessed in vessels between 5 and 25 mm RBC column width. A wide range of variability in PBR
measurements, with a mean PBR of 2.14 mm (range: 1.43–2.86 mm), was observed. Linear regression analysis showed a
marked association between PBR and microvascular perfusion, reflected by RBC filling percentage (regression coefficient b:
20.034; 95% confidence interval: 20.037 to 20.031). We conclude that microvascular beds with a thick (‘‘healthy’’)
glycocalyx (low PBR), reflects efficient perfusion of the microvascular bed. In contrast, a thin (‘‘risk’’) glycocalyx (high PBR) is
associated with a less efficient and defective microvascular perfusion.
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Introduction
Cardiovascular disease is the leading cause of death in
developed countries and one of the earliest changes in the
pathogenesis of cardiovascular disease is microvascular dysfunc-
tion [1]. Within the inner vessel wall, a luminal endothelial
glycocalyx is strategically located to continuously interact with the
flowing blood. This endothelial glycocalyx is a thick gel-like
meshwork of proteoglycans, glycosaminoglycans and plasma
proteins; it functions as an important biological modifier in the
interaction between the blood and the vessel wall [2,3].
Degradation and modification of the endothelial glycocalyx is,
therefore, thought to be one of the earliest changes occurring in
the pathogenesis of vascular disease [4,5]. For example, the
endothelial glycocalyx exerts an anti-inflammatory and anti-
thrombotic role by covering various glycoprotein adhesion
receptors for leukocytes [6] and platelets [7]. Also, the endothelial
glycocalyx has a protective role against protein leakage, as shown
by our group previously, when selective degradation of endothelial
glycocalyx with hyaluronidase led to glomerular albumin leakage
[4].
Another function of the endothelial glycocalyx has been
proposed to be the regulation of microvascular perfusion. The
concept that the glycocalyx contributes to the regulation of
microvascular perfusion was originally hypothesized by the group
of Duling in 1990 when they showed that the adenosine-induced
increase in capillary tube hematocrit in hamster cremaster muscle
vessels was diminished after enzymatic glycocalyx degradation [8].
Further evidence for the role of the glycocalyx in regulation of
functional microvascular perfusion has subsequently been gath-
ered [9–13]. Changes in glycocalyx composition have been
demonstrated to result in a decrease of shear- dependent nitric
oxide (NO) -mediated arteriolar vasodilation [14], to decrease
functional capillary density [15] and to induce platelet- and
leukocyte adhesion in microvessels [6,7,16]; all effects that
potentially affect microvascular perfusion. Loss of microvascular
perfusion is a principal process in chronic organ failure, including
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heart, kidney and vascular dementia. The central concept is that
endothelial (EC) activation turns pericytes into myofibroblasts,
resulting in loss of capillaries, tissue hypoxia and subsequent organ
fibrosis. However, there is currently no data on the relation
between health of the endothelial glycocalyx and microvascular
perfusion regulation in man.
Of the several methods to measure glycocalyx health in vivo, we
have utilized the property of the endothelial glycocalyx to function
as a barrier to maintain a certain distance between red blood cells
(RBC) and the endothelial cell membrane [17–19]. To determine
the spatio-temporal variation in radial displacement of individual
RBCs into the endothelial glycocalyx in microvessels we used
sidestream darkfield (SDF) imaging. SDF imaging is a non-invasive
technique which visualizes hemoglobin within the RBC by
reflected light emitting diode (LED) light from the microvascula-
ture [20]. With this technique, it has been shown that the RBCs
(diameter of 7 to 8 mm) maintain a certain distance from the
endothelium of capillaries (diameter of 5 mm), which was
postulated to be due to the barrier function of the glycocalyx
against the RBC [19]. Using SDF imaging, we imaged the
longitudinal and radial distribution of RBC in sublingual
microvessels to obtain information about the in vivo endothelial
glycocalyx barrier properties in humans [21]. This concept has
recently been tested in various patient groups with cardiovascular
disease or risk factors, such as end-stage renal disease [17,21],
stroke [18], premature coronary artery disease [22] and critically
ill patients (septic and non-septic)[23], in which it was indicated
that a perturbed glycocalyx allowed the erythrocytes to penetrate
deeper towards the endothelium, resulting in an increase in the
perfused boundary region (PBR). In addition to the lateral RBC
movements, the longitudinal presence of RBCs (along known as
vascular segments per surface area) is measured, allowing a
simultaneous examination of the glycocalyx exclusion properties
and the microvascular spatio-temporal RBC perfusion. We
hypothesized that impaired glycocalyx barrier properties in the
sublingual microcirculation is associated with changes in micro-
vascular perfusion capacity in the general population.
Methods
Study Design and study population
We performed a cross-sectional analysis among participants
recruited for the Netherlands Epidemiology of Obesity (NEO)
study [24] to examine the association between endothelial
glycocalyx integrity and microvascular perfusion. The NEO study
is a population-based, prospective cohort study of 6,673 individ-
uals aged between 45 and 65 years, with oversampling of
overweight and obese individuals, to study pathways that lead to
obesity-related diseases for a better understanding of the mech-
anisms underlying development of disease in obesity.
Detailed information about the study design and data collection
has been described previously [24]. Men and women aged
between 45 and 65 years with a self-reported BMI of 27 kg/m2 or
higher and living in the greater area of Leiden (in the west of the
Netherlands) were eligible to participate in the NEO study. In
addition, all inhabitants aged between 45 and 65 years from one
municipality (Leiderdorp, the Netherlands) were invited, irrespec-
tive of their BMI, allowing for a reference BMI distribution. SDF
imaging was performed in a random subgroup of 937 participants
from the 1394 participants who were included from January 2012
to October 2012. The study was carried out in accordance with
the Declaration of Helsinki. Approval was obtained from the
Committee of Medical Ethics of Leiden University Medical Center
and all participants gave written informed consent.
General Measurements
Prior to the NEO study visit, participants completed a
questionnaire about demography, lifestyle and medical history
and fasted for at least 10 hours. Participants came to the research
site in the morning to undergo several baseline measurements
including anthropometric measurements, and blood sampling.
Hemoglobin (Hb) was measured by the SLS hemoglobin detection
method and hematocrit (Hct) by the RBC cumulative pulse height
detection method with a Sysmex XE-2100 system (Sysmex, UK).
Extensive physical examination was conducted, including
anthropometry and blood pressure measurements. Blood pressure
was measured three times in a seated position on the right arm
with a 5 minutes resting interval using a validated automatic
oscillometric device (OMRON, Model M10-IT, Omron Health
Care Inc., IL, USA). Prehypertension and hypertension were
diagnosed according to JNC 7 criteria [25].
Imaging of microcirculation
Intravital microscopy was performed at bedside with a SDF
camera (MicroVision Medical Inc., Wallingford, PA) to visualize
the sublingual microvasculature. The SDF camera uses green light
emitting diodes (540 nm) to detect the hemoglobin of passing
RBC. The images were captured using a 56 objective with a 0.2
NA (numerical aperture), providing a 325- fold magnification in
7206576 pixels (tissue dimension: 9506700 mm; tissue area:
0.665 mm2) at 23 frames per second. The system makes up to
840 measurements of the width of the RBC column at a specific
site. These individual width measurements are obtained after 8-
fold pixel size interpolations of the corresponding radial intensity
profiles, allowing detection of small changes in width between
individual width measurements as small as 0.1 mm, which
translates in accuracy of estimates of boundary layer of approx-
imately 0.05 mm. The image acquisition is automatically mediated
through the Glycocheck software (Glycocheck BV, Maastricht, the
Netherlands) (Figure 1. for illustration of software algorithm). It
detects the dynamic lateral RBC movement into the glycocalyx,
which is expressed as the perfused boundary region (PBR, in mm).
Therefore, a perturbed or degraded glycocalyx would allow more
RBCs to penetrate deeper towards the endothelial surface, which
is reflected by an increase in PBR (figure 1d.). The method of
calculating the PBR has been used and validated in various
publications [17,18,21–23].
In short, the software automatically identifies all available
measurable micro-vessels (below 30 mm thickness) during the
acquisition by contrast between the RBC and the background, in
focus and without movement of the imaging unit (raw data in
figure 1a). With this, it places vascular segments every 10 mm
along the length of these vessels. Subsequently, a sequence of 40
frames is recorded containing, on average, 300 major vascular
segments (depicted as green lines in figure 1b). Next, the observer
moves the camera to a different location to record another 40
frames, until a minimum total of 3,000 vascular segments are
placed. After acquisition, the software undergoes a series of quality
checks to only measure vascular segments that are of good quality.
First, on the first frame of each recording session, ten line markers
are placed every 0.5 mm along each side of the vascular segments
(total of 21 line markers). Only those that have sufficient contrast
on more than 60% of the 21 line markers of each vascular segment
are considered a valid vascular segment (green lines in figure 1c),
in contrast to the invalid vascular segment (yellow lines in
figure 1c). Since all vascular segments are placed every 10 mm, the
length of perfused microvascular length can be expressed by
multiplying 10 mm and the number of valid vascular segments per
area of tissue visualized (valid microvascular density). For the
Glycocalyx and Microvascular Perfusion
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second quality check, during the measurement of RBC column
widths for all 40 frames of recording session, the software screens
for minimal RBC width, position of RBC column and the signal-
to-noise ratio. At this step, the software calculates the percentage
of vascular segments with RBC present during all 40 frames of the
recording session, to determine the RBC filling percentage. Both
the valid microvascular density and the RBC filling percentage
were used as an estimate for the microvascular perfusion. For the
last quality check, the curve fit for calculating the median RBC
column widths is tested also for irregularities (figure 1e). Thus,
after all these quality checks, those that fulfill these criteria are
subject to analysis for the radial distribution of RBC, as a
measurement of glycocalyx function.
For each vascular segment, the dynamic lateral position of
RBCs (per RBC column width) is determined. The intensity
profiles of the distribution of RBC column widths are used to
calculate a cumulative distribution. From this distribution, the
median RBC column width is obtained while a linear regression
analysis of the RBC column width is performed to derive the
perfused diameter (the X-axis intercept of the extrapolated
regression line) is calculated (figure 1f). Then, the PBR is defined
as the distance between RBC column width and perfused diameter
and is calculated using the equation, ([Perfused diameter – median
RBC column width]/2). Next, the calculated PBR values,
classified according to their corresponding RBC column width
between 5–25 mm, are averaged to provide a single PBR value for
each participant.
Statistical Analysis
In the NEO study there is an oversampling of persons with a
BMI of 27 kg/m2 or higher. For the present study, to correctly
represent associations in the general population [26], adjustments
for the oversampling of individuals with a BMI $27 kg/m2 were
made. This was done by weighting individuals towards the BMI
distribution of participants from the Leiderdorp municipality,
whose BMI distribution was similar to the BMI distribution of the
Figure 1. Glycocheck algorithm on endothelial PBR determination and microvascular perfusion properties. A) Red blood cells (RBC)
are detected through reflection of light emitting diodes by hemoglobin. Images captured by the sidestream darkfield camera are sent to the
computer for quality checks and assessment. The black contrast is the perfused lumen of the vessels. B) In each recording, the software automatically
places the vascular segments (green), every 10 mm along the vascular segments (black contrast). C) After the acquisition, for the analysis, the software
undergoes several quality check in the first frame of each recording (see text), to select vascular segments with sufficient quality for further analysis.
Invalid vascular segments (yellow) are distinguished from the valid vascular segments (green). During the whole recording session of 40 frames, the
percentage of time in which a particular valid vascular segment has RBCs present is used to calculate RBC filling percentage. D) Depiction of the
concept of glycocalyx thickness by lateral RBC movement is shown here. E) For each vascular segment, the intensity profile is calculated to derive
median RBC column width. F) Then, the distribution of RBC column width is used to calculate the perfused diameter, median RBC column width, and
subsequently the perfused boundary region (PBR).
doi:10.1371/journal.pone.0096477.g001
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general Dutch population [26]. All results were based on weighted
analyses. Consequently, results apply to a population-based study
without an oversampling of BMI $27 kg/m2.
Participants with unsuccessful measurements through SDF
imaging (including participants with incomplete recording sessions
(less than 10; n= 16) and abnormal video images, such as
consistent presence of air bubbles (n = 6), all PBR outlier values),
preventing correct analysis were excluded (n = 22). In the end, 915
participants were included in the analysis of data. Baseline
characteristics of the population were expressed as mean
(6standard deviation [SD]), median (interquartile range), or as
percentage. We performed linear regression analysis to investigate
the associations of perfused boundary region with RBC filling
percentage and valid microvascular density, while adjusting for
age and sex. All statistical analyses were performed using SPSS
version 20.0 (Chicago, IL), STATA Statistical Software (Statacorp,
College Station, Texas) and GraphPad version 5.0 (GraphPad
Prism Software Inc., San Diego, CA). A p-value ,0.05 was
defined as statistically significant.
Results
General clinical characteristics
The clinical characteristics of individuals with measured SDF
are shown in Table 1. All participants were between 45 to 65 year
old. Of all participants, 42% were lean, 42% were overweight, and
16.0% were obese. The mean systolic blood pressure was
131 mmHg (S.D.: 16 mmHg) and diastolic blood pressure was
83 mmHg (S.D.: 10 mmHg), with 36% with hypertension.
Determination of microcirculatory properties
From the RBC column width and perfused diameter, perfused
boundary region was calculated to derive the glycocalyx barrier
function (Table 2, #1 to #3). Overall, the mean PBR was
2.14 mm with a wide range of variability (range: 1.43–2.86 mm)
(table 2). Despite the wide distribution of PBR in our cohort, there
was a difference in PBR between men and women (mean: 2.09 mm
and 2.18 mm, respectively).
In addition to the glycocalyx barrier function by means of PBR,
microvascular perfusion outcomes were calculated, resulting in a
mean valid microvascular density of 3213 mm/mm2 (table 2, #5)
and a mean RBC filling percentage of 73.2% (table 2, #6). In
other words, there is 3246 mm of perfused microvessels per mm2 of
tissue area which was in 73.2% positive for the presence of RBCs
at a given time point during the 40 frames of video recording.
Association of the glycocalyx barrier properties with
microcirculatory perfusion
To test the hypothesis whether impaired glycocalyx barrier
properties are associated with impaired microvascular perfusion,
we examined the association between PBR and the two used
estimates for microvascular perfusion (Table 3 and figure 2). Of
the two microvascular perfusion outcomes, RBC filling percentage
was associated with PBR (regression coefficient b: 20.034; 95%
CI: 20.037 to 20.031) and explained 47% of variability of
perfused boundary region (R2: 0.475, p,0.001). The valid
microvascular density was also associated with PBR but explained
the variability of PBR to a lesser extent (R2: 0.030), although still
significant. Examples of video-clips obtained from participants
with different PBR values and corresponding changes in
Table 1. General Clinical Characteristics.
Total (n = 915)
Gender (% of male/female) 46/54
Age (year) 56.166.0
BMI (kg/m2) 26.464.2
Hb (mmol/L) 8.7161.1
Hct 0.4160.12
Hypertension (%) 33.5%
Systolic BP (mmHg) 131.0616.2
Diastolic BP (mmHg) 83.269.7
Hb, hemoglobin; Hct, hematocrit; BP, blood pressure. Data is presented as mean 6 standard deviation.
doi:10.1371/journal.pone.0096477.t001
Table 2. Sidestream darkfield imaging derived variables characteristics.
# Parameter Total Men Women
1 RBC Column width (mm) 10.5661.12 10.7461.10 10.4161.11
2 Perfused diameter (mm) 14.8461.18 14.9261.19 14.7761.17
3 Perfused boundary region (mm) 2.1460.25 2.0960.24 2.1860.25
4 Total microvascular density (mm/mm2) 43146882 42236821 43916924
5 Valid microvascular density (mm/mm2) 32136691 31446627 32726736
6 RBC filling (%) 73.265.0 74.064.8 72.465.0
Data is presented as mean 6 standard deviation.
doi:10.1371/journal.pone.0096477.t002
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microvascular perfusion are shown in Movie S1 and S2 (high and
low PBR, respectively).
Discussion
We have measured the RBC accessibility into the endothelial
glycocalyx, i.e. perfused boundary region (PBR) together with
RBC filling percentage and valid microvascular density in the
sublingual microvasculature of over 900 participants recruited for
the NEO study.
In this study we observed a strong association between changes
in endothelial glycocalyx properties (PBR) and estimates of
microvascular perfusion in the sublingual microcirculation
(Figure 2 and Table 3). The strongest association existed between
PBR and RBC filling percentage, which represents the microvas-
cular perfusion changes over time.
The mechanically stable gel-like layer on the endothelial surface
limits the area in which RBCs and large plasma proteins are
distributed (RBC exclusion properties of glycocalyx), which is
reflected by a low PBR (figure 3a). An earlier observation of
individual RBC in capillaries showed that compression of the
RBCs by intact glycocalyx result in more elongated RBCs (7–
8 mm length and 3–4 mm width), and therefore a more efficient
and faster passage of these RBCs [19]. Also, this would lead to
increased RBC longitudinal passage, allowing more oxygen
exchange capacity. The relation between PBR and vascular
perfusion has been studied, however, in a variety of different
physiological stimulants, such as by exercise, nitroglycerine,
adenosine or insulin [9,10,22]. For instance, nitroglycerine
challenge in a healthy population led to an increase in PBR and
a recruitment of reserve capacity, further arguing that in a healthy
state of acute physiological need, the glycocalyx has the potential
to become more porous to facilitate the increased metabolic
demand [10]. With such transient stimuli, both PBR and perfusion
increases, leading to a temporary local increase in oxygen/nutrient
exchange. Therefore the observed variation in PBR and its
correlation with perfusion could theoretically be explained by this
dynamic regulation. Nonetheless, we have performed our mea-
surements in a strictly controlled environment (e.g. overnight
fasting, resting for more than 15 minutes, exclusion of caffeine and
smoking). Thus, the observed variation in PBR and clear negative
correlation (figure 2b) with the microvascular perfusion would
argue for differences in vascular health in our population.
Therefore, in an unhealthy vascular state, PBR increase
(reflecting increased outward penetration of RBC) together with
decreased RBC filling percentage and functional microvascular
density, reflects poor perfusion (figure3b). When the glycocalyx is
degraded for a prolonged time, protein extravasation increases
with subsequent edema formation [4,27], and a reduction in nitric
oxide bioavailability [14], all together leading to endothelial
Figure 2. Scatterplot between PBR and outcomes of microvascular perfusion. The perfused boundary region (PBR), a measurement for
glycocalyx accessibility to red blood cells (RBC), is associated significantly with spatio-temporal aspects of microvascular perfusion variables: A) RBC
filling percentage (percentage of time in which a particular vascular segment is perfused) B) Valid microvascular density. In particular, lower PBR (less
accessible glycocalyx, thus a better and thicker glycocalyx) is associated with higher RBC filling percentage (temporal perfusion).
doi:10.1371/journal.pone.0096477.g002
Table 3. Linear regression analysis show association between perfused boundary region and microvascular perfusion parameters.
Independent variable* Regression coefficient b R-Square 95% CI for coefficient b
{
Lower Bound Upper Bound
RBC filling percentage 20.034 0.475 20.037 20.031
+Age, sex, BMI` 20.034 0.482 20.036 20.031
Valid microvascular density1 20.054 0.02 20.083 20.025
+Age, sex, BMI` 20.059 0.06 20.087 20.030
*Dependent variable: Perfused boundary region (PBR).
{95% confidence interval for regression coefficient b.
`Linear regression analysis adjusted for age, sex and BMI.
1Valid microvascular density expressed as millimeter of microvessel length per mm2 of area of tissue (mm/mm2) for linear regression analysis due to difference in scale
from PBR.
doi:10.1371/journal.pone.0096477.t003
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dysfunction and perfusion defects [10,15]. For instance, in patients
with diabetes, there is increased hyaluronidase activity [28], which
probably decreases glycocalyx volume and functional capillary
density [15,28,29]. The increase in distance between RBCs
(reflected by low RBC filling percentage) might be due to both
RBC changes into a wider shape [19] and more intravascular
volume in which RBC could distribute. Ultimately, these changes
lead to slow, diffuse and inefficient perfusion [30], as schematically
depicted in figure 3.
Variability in the width of the RBC column, and thus PBR
could theoretically also decrease to lower values when the
glycocalyx layer becomes very thin. However, it is empirically
and consistently found in all available and known (clinical) data,
that PBR progressively increases with the severity of disease and
glycocalyx damage. The most striking increases in PBR are found
in critically diseased patients with severe septic shock in the ICU
(unpublished data), who are supposed to have shed off the
glycocalyx [6,23]. In these subjects the level of PBR increase
correlates directly with mortality and cardiovascular organ
complications. It therefore appears that relatively infrequent
deeper penetration of RBCs into the layer during degradation/
damage of glycocalyx precedes the radial outside movement of the
majority of the RBCs in the RBC column, resulting in increases in
PBR on top of potential increases in median width of the RBC
column. Moreover, in the present study, we performed the
measurements in a large group of relative healthy participants,
making the loss of glycocalyx in the microvasculature also a
relative unlikely event.
A question obviously is, whether glycocalyx assessment of the
sublingual microcirculation is representative for glycocalyx
dimensions in other tissues. Glycocalyx thickness and functional
properties may indeed differ substantially from one organ to
another [31]. However, as with other measurements of endothelial
function, systemic factors will affect representative functional
endothelial changes throughout the circulation. For example,
using the SDF technique we and others have shown that
sublingual vascular changes correlate with changes in the
microvasculature of gastric, renal and nervous system organs
[17,18,21,32–38]. In addition, we have shown in diabetic subjects
that glycocalyx dimensions correlated with systemic glycocalyx
volume changes [28]. Also, changes in the sublingual PBR in
patients with coronary artery disease or stroke imply that local
microvascular abnormalities indeed reflect changes in the systemic
microvasculature [18,22].
During the past few years, there have been several methodo-
logical advances introduced in estimating glycocalyx dimensions.
In the past, SDF glycocalyx dimensions were calculated as the
difference in RBC column width before (functionally perfused
capillary diameter) and after (anatomical capillary diameter)
leukocyte passage [28,39]. Thereby, it measures the transient
change in thickness due to leukocyte- induced compression of the
glycocalyx. These previous measurements have shown reduced
glycocalyx dimensions in various cardiovascular diseases such as
diabetes [28,29], obesity [39], and hypercholesterolemia [40].
However, it is a labor-intensive process by manually capturing
leukocyte passages for a longer time period and analyzing the
results. In addition, it is subject to investigator bias. The current
method of SDF imaging we have used, which detects the dynamic
changes in the erythrocyte movements, acquires and analyses the
recordings in an unbiased, fully automated fashion.
While this technique estimates the glycocalyx thickness and
microvascular perfusion non-invasively and automatically, it does
have its limitations. First, the SDF camera only detects RBCs.
Therefore, the perfused diameter and PBR is not the anatomical
diameter of the vessel or the thickness of the anatomical
glycocalyx, respectively. Nonetheless, by measuring the distribu-
tion of RBCs in a dense spatio-temporal manner, the software
measures the location of the RBCs and can thereby statistically
calculate the perfused diameter and PBR. In addition, we have
recently validated that the measurement for PBR reflects actual
anatomical glycocalyx damage, as shown by reduced distance
between endothelial cell and RBC after hyaluronidase treatment
using intravital microscopy [21]. Second, by visualizing the spatio-
temporal location of the RBCs, the software estimates the
microvascular perfusion by how often a certain vascular segment
has a passing RBC. However, conventional outcome of perfusion
variables includes RBC velocity or the anatomical microvascular
density in a tissue [32]. Also, during the acquisition of
approximately 2 seconds, the software cannot detect the vessel if
there are no RBCs passing through. Therefore, it cannot visualize
all vessels.
Figure 3. Schematic illustration on relation between glycocalyx
accessibility and microvascular perfusion regulation. A) Healthy
state: Intact glycocalyx prevents red blood cells (RBC, red dots) from
penetrating into its domain, reflected by a low perfused boundary
region (PBR), and nicely aligned elongated RBC. The vessels are well
perfused (higher tube hematocrit of microvessel and elongated shape
of erythrocyte) resulting in a higher percentage of vessel segments with
RBC present at any particular time point (high RBC filling percentage).
B) Risk State: Altered composition of glycocalyx (lined dots) allows RBCs
to penetrate deeper into the glycocalyx, closer to the anatomical border
of lumen (endothelium), reflected by the high PBR. Due to the widening
of RBC distribution width and volume, there is more space in between
each RBC, as shown by decreased RBC filling percentage (less positive
contrast per vascular segment per time point). Also, prolonged state of
glycocalyx degradation leads to edematous and non-functioning
vessels, leading to shorter vessel density per area of tissue (reduced
valid microvascular density in risk PBR), depicted by the loss of bottom
vessel.
doi:10.1371/journal.pone.0096477.g003
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In conclusion, SDF imaging of the mucosal microvasculature in
an adjusted subgroup of participants recruited for the NEO study,
to represent associations in a general population, showed a wide
range of variability in RBC accessibility to the glycocalyx, which
was negatively associated with microvascular perfusion. This
means that with a thick (‘‘healthy’’) glycocalyx (reflected by a low
PBR) there is efficient perfusion of the microvascular bed. In
contrast, a thin (‘‘risk’’) glycocalyx (reflected by a high PBR) is
associated with less efficient and perturbed perfusion. The strong,
and until now unknown, correlations of PBR with microvascular
perfusion in man, indicate that values of PBR might allow us to
report on relations between these parameters during follow up of
these subjects, and relate it to future cardiovascular risk. This is
clinically very relevant as microvascular rarefaction is a principal
process in development of chronic organ failure.
Supporting Information
Movie S1 Video clip of participants with high perfused
boundary region with altered microvascular perfusion.
A single recording session (from ten or more recording sessions per
measurement) is extracted from random participants with high
and low (Movie S2) PBR to illustrate the difference in level of
perfusion. Video clip of a participant with high PBR (2.52 mm)
shows altered microvascular perfusion. Descriptively, the move-
ment of RBCs seem sluggish. Automated quantitative analysis
through the software shows that the RBC filling percentage was
65.3% and the functional microvascular density (total length of
perfused vessel per area of tissue) is 1985 mm/mm2.
(AVI)
Movie S2 Video clip of participants with low perfused
boundary region with normal microvascular perfusion.
Video clip of a participant with low PBR (1.84 mm) shows fast and
efficient passage of RBCs through the microvessels. Quantitatively,
the functional microvascular density is longer 6782 mm/mm2
compared to that of participant with high PBR (in Movie S1). The
RBC filling percentage of this participant was higher at 74.1%,
which means that the time in which a particular vascular segment
contains an RBC present is increased. Note: While the functional
microvascular density is based on the individual video clip, the
PBR and RBC filling percentage are not just from the shown video
clip, but calculated from all recording sessions.
(AVI)
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